Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali
Cancer and chemotherapy-induced anemia (CIA) is a common complication in patients undergoing active chemotherapy, with or without radiation therapy. In this video, Dr Aditya Murali, Senior Consultant, Medical Oncology and Hemato-Oncology at Apollo Hospitals, Bannerghatta Road, Karnataka, presents a real-world case highlighting the challenges and effective management of CIA in a patient with metastatic breast cancer.
He discusses the role of darbepoetin alfa (Cresp) in improving and maintaining hemoglobin levels, enhancing patient tolerance to therapy, and ensuring continuity of cancer treatment. The case involves a 71-year-old woman diagnosed with metastatic carcinoma of the right breast, with confirmed metastases to the lungs, axillary lymph nodes, and bones.
This video offers valuable insights into how CIA can be successfully managed with darbepoetin alfa, providing practical guidance for oncologists in real-world clinical settings.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.